Robert Francomano
Keine laufenden Positionen mehr
Vermögen: 33 724 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Robert Francomano
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 12 | |
Public Company | Pharmaceuticals: Major | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robert Francomano
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CELGENE | Biotechnology | Corporate Officer/Principal | |
ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Director/Board Member | |
ACADIA REALTY TRUST | Real Estate Investment Trusts | Director/Board Member Director/Board Member | |
INTERMUNE INC | Biotechnology | Corporate Officer/Principal | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
SEAGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Brown Advisory, Inc.
Brown Advisory, Inc. Financial ConglomeratesFinance Brown Advisory, Inc. provides investment and advisory services. It specializes in investment management, strategic advisory, wealth management, and private equity. The firm provides services to individuals, families, institutions, and corporations. The company was founded in 1993 and is headquartered in Baltimore, MD. | Financial Conglomerates | Director/Board Member | |
IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Director/Board Member | |
SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | General Counsel | |
Summit Foundation | Director/Board Member | ||
University of Pennsylvania | College/University | Undergraduate Degree | |
GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Director/Board Member Chief Executive Officer | |
State University of New York at Albany | College/University | Undergraduate Degree | |
University of Durham | College/University | Undergraduate Degree | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
GENFIT | Pharmaceuticals: Major | Director/Board Member | |
Bar-Ilan University | College/University | Graduate Degree | |
Supreme Court of the United States | General Government | Corporate Officer/Principal | |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ATHERSYS, INC. | Biotechnology | Director/Board Member | |
Kirby Mcinerney LLP
Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mckinsey & Co. SAS
Mckinsey & Co. SAS Miscellaneous Commercial ServicesCommercial Services Mckinsey & Co. SAS provides business and management consulting services. The company is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Columbia Law School | College/University | Graduate Degree | |
Leumi Partners Underwriters Ltd. | Corporate Officer/Principal | ||
Robert H. Smith School of Business | College/University | Masters Business Admin | |
United States District Court for the Eastern District of NY | General Government | Corporate Officer/Principal | |
United States District Court for the Southern District of NY | General Government | Corporate Officer/Principal | |
Drexel University College of Medicine | College/University | Doctorate Degree | |
United States Court of Appeals For The Fourth Circuit | Corporate Officer/Principal | ||
Harvard Business School | College/University | Masters Business Admin | |
The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Frontier Equities VC LLC
Frontier Equities VC LLC Investment ManagersFinance Frontier Equities VC LLC (Frontier Equities) is a venture capital firm founded in 2011 by Mark Sard. The firm is headquartered in New York, United States. | Investment Managers | Founder | |
United States Court of Appeals for the Second Circuit | Corporate Officer/Principal | ||
Clinical Genomics Technologies Pty Ltd.
Clinical Genomics Technologies Pty Ltd. Medical/Nursing ServicesHealth Services Clinical Genomics Technologies Pty Ltd. manufactures and sells healthcare solutions for the early detection and prevention of disease. The company was founded by Lawrence LaPointe, Richard J. Sands and Susanne K. Pedersen in September 2006 and is headquartered in North Ryde, Australia. | Medical/Nursing Services | Director/Board Member | |
Victorian College of The Arts | College/University | Undergraduate Degree | |
PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Greenwich Biosciences, Inc.
Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
IN8BIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Pepperdine Graziadio Business School | College/University | Masters Business Admin | |
PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Epygenix Therapeutics, Inc.
Epygenix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Epygenix Therapeutics, Inc. manufactures drugs products that treat dravet syndrome and genetic epilepsies. It offers Dravet Syndrome, Lennox-Gastaut Syndrome, Infantile Spasm, and Otahara syndrome. The company was founded by Hahn-Jun Lee and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
NUVECTIS PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder Founder | |
Daniel M. Hume, M.D. PA | President | ||
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member |
Statistik
International
Vereinigte Staaten | 40 |
Israel | 5 |
Vereinigtes Königreich | 3 |
Frankreich | 3 |
Australien | 3 |
Sektoral
Health Technology | 23 |
Consumer Services | 13 |
Finance | 5 |
Government | 4 |
Commercial Services | 4 |
Operativ
Director/Board Member | 46 |
Corporate Officer/Principal | 22 |
Independent Dir/Board Member | 17 |
Undergraduate Degree | 11 |
Chief Executive Officer | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Darren Cline | 15 |
Eric Dobmeier | 14 |
Daniel Hume | 14 |
Ronald Bentsur | 13 |
Kenneth Zuerblis | 12 |
Alan Forman | 11 |
Katherine Kalin | 10 |
Trishna Goswami | 6 |
Mark Sard | 4 |
Enrique Poradosu | 4 |
Shay Shemesh | 4 |
Andrew Elnatan | 4 |
Nassir Habboubi | 1 |
Jeffrey Levitt | 1 |
- Börse
- Insiders
- Robert Francomano
- Unternehmensverbindungen